心臟安全服務市場規模、佔有率及成長分析(按服務、類型、最終用途和地區分類)-2026-2033年產業預測
市場調查報告書
商品編碼
1915851

心臟安全服務市場規模、佔有率及成長分析(按服務、類型、最終用途和地區分類)-2026-2033年產業預測

Cardiac Safety Services Market Size, Share, and Growth Analysis, By Services (ECG/Holter Monitors, Blood Pressure Monitors), By Type (Integrated, Standalone), By End Use, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 192 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球心臟安全服務市場規模預計在 2024 年達到 8.2436 億美元,從 2025 年的 9.1834 億美元成長到 2033 年的 21.7813 億美元,在預測期(2026-2033 年)內複合年成長率為 11.4%。

由於心血管疾病盛行率上升、藥物研發活動活性化以及監管壓力加大,全球心臟安全服務市場正經歷顯著成長。服務外包趨勢日益明顯,心電圖 (ECG) 數據分析技術的進步進一步推動了這一趨勢。將人工智慧 (AI) 應用於心臟安全監測可顯著提高評估的品質和效率。在臨床試驗數量不斷增加以及對早期發現心血管風險的迫切需求的推動下,服務供應商正在擴展其心電圖服務範圍,將遙測和 QT 間期監測納入其中。這一發展趨勢正在推動製藥和生物技術行業的需求,同時也促進了更整合和集中的心臟安全數據管理,最終提高試驗效率並降低風險。

全球心臟安全服務市場促進因素

隨著心血管、腫瘤和中樞神經系統藥物研發活動的活性化,對心臟安全監測的需求日益成長。為此,監管機構制定了嚴格的全面心臟安全評估要求,凸顯了專業服務的必要性。對心臟評估的日益重視推動了對先進監測解決方案的需求,包括心電圖、連續型心電圖監測和QT間期分析。因此,全球心臟安全服務市場持續擴張,反映出確保這些高風險醫療領域新治療性介入的安全性和有效性至關重要。

限制全球心臟安全服務市場的因素

全球心臟安全服務市場面臨嚴峻挑戰,因為先進的心電圖監測系統、遙測設備和人工智慧驅動的分析平台需要大量的資本投入。這種財務負擔構成了重大障礙,尤其對中小型藥廠而言,更增加了心臟安全服務的成本。隨著這些公司努力應對實施先進技術的相關成本,市場成長可能會放緩。大量的資源投入可能會削弱這些機構的有效競爭能力,並影響其在心臟安全領域的整體參與。

全球心臟安全服務市場趨勢

全球心臟安全服務市場正經歷著向分散式臨床試驗的重大轉變,推動了遠距心臟監測解決方案的普及。這一趨勢的驅動力在於穿戴式心電圖設備、行動醫療應用和雲端遙測平台的日益融合,使得在傳統臨床環境之外進行即時數據採整合為可能。這種轉變不僅提升了受試者的便利性,也擴大了目標患者群體,並簡化了資料收集流程。隨著醫療保健領域數位轉型的不斷推進,心臟監測技術的進步有望提升病人參與,最佳化臨床療效,並促進心臟安全評估調查方法的改進。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 技術分析
  • 顧客購買行為分析

全球心臟安全服務市場規模(依服務類型分類)及複合年成長率(2026-2033 年)

  • 心電圖(ECG)/心電圖監測
  • 血壓監測儀
  • 心血管影像
  • 其他

全球心臟安全服務市場規模(按類型和複合年成長率分類)(2026-2033 年)

  • 融合的
  • 獨立版

全球心臟安全服務市場規模(按最終用途和複合年成長率分類)(2026-2033 年)

  • 製藥和生物製藥公司
  • CRO
  • 其他

全球心臟安全服務市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • IQVIA
  • PPD Inc,
  • Charles River Laboratories
  • Welly sis
  • Eurofins Scientific
  • Celerion
  • Nova Research Laboratories
  • Laboratory Corporation of America Holdings
  • Konin klije Philips NV
  • ICON Plc.
  • SGS SA
  • Clario
  • Viva Link
  • Certara
  • Richmond Pharmacology
  • Biotrial

結論與建議

簡介目錄
Product Code: SQMIG35D2348

Global Cardiac Safety Services Market size was valued at USD 824.36 Million in 2024 and is poised to grow from USD 918.34 Million in 2025 to USD 2178.13 Million by 2033, growing at a CAGR of 11.4% during the forecast period (2026-2033).

The global cardiac safety services market is experiencing significant growth due to the rising prevalence of cardiovascular diseases, heightened drug development activities, and increasing regulatory pressures. The trend of outsourcing services is on the rise, further amplified by advancements in technology for analyzing electrocardiogram (ECG) data. The incorporation of artificial intelligence (AI) in cardiac safety monitoring significantly enhances the quality and efficiency of assessments. With an uptick in clinical trials and a pressing need for early detection of cardiovascular risks, service providers are expanding their ECG offerings, including telemetry and QT monitoring. This evolution is fostering demand across pharmaceutical and biotechnology sectors while promoting more integrated, centralized cardiac safety data management, ultimately leading to improved trial efficiencies and reduced risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Safety Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Safety Services Market Segments Analysis

Global Cardiac Safety Services Market is segmented by Services, Type, End Use and region. Based on Services, the market is segmented into ECG/Holter Monitors, Blood Pressure Monitors, Cardiovascular Imaging and Others. Based on Type, the market is segmented into Integrated and Standalone. Based on End Use, the market is segmented into Pharma & Biopharma Companies, CROs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Safety Services Market

The increasing activity in drug development, particularly concerning cardiovascular, oncology, and central nervous system therapies, underscores the growing demand for cardiac safety monitoring. As a result, regulatory bodies have established stringent requirements for comprehensive cardiac safety evaluations, emphasizing the necessity for specialized services. This heightened focus on cardiac assessments drives the need for advanced monitoring solutions such as ECG and Holter monitoring, as well as QT interval analysis. Consequently, the global market for cardiac safety services is expanding, reflecting the critical importance of ensuring the safety and efficacy of new therapeutic interventions in these high-stakes areas of healthcare.

Restraints in the Global Cardiac Safety Services Market

The Global Cardiac Safety Services market faces significant challenges due to the high capital investment needed for advanced ECG monitoring systems, telemetry devices, and AI-driven analytics platforms. This financial burden can be particularly daunting for small and medium-sized pharmaceutical companies, leading to increased costs for cardiac safety services. As these companies grapple with the expenses associated with implementing such sophisticated technologies, it may result in a slowdown in market growth. The necessity for substantial resource allocation can hinder these organizations' ability to compete effectively, thereby impacting their overall participation in the cardiac safety landscape.

Market Trends of the Global Cardiac Safety Services Market

The Global Cardiac Safety Services market is witnessing a significant shift towards decentralized clinical trials, driving the adoption of remote cardiac monitoring solutions. This trend is fueled by the increasing integration of wearable ECG devices, mobile health applications, and cloud-based telemetry platforms, allowing real-time data capture outside traditional clinical environments. The shift not only enhances convenience for participants but also expands accessible patient demographics and streamlines data collection processes. As healthcare increasingly embraces digital transformation, these advancements in cardiac monitoring are poised to improve patient engagement, optimize clinical outcomes, and facilitate more efficient research methodologies in cardiac safety assessments.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Analysis
  • Customer Buying Behavior Analysis

Global Cardiac Safety Services Market Size by Services & CAGR (2026-2033)

  • Market Overview
  • ECG/Holter Monitors
  • Blood Pressure Monitors
  • Cardiovascular Imaging
  • Others

Global Cardiac Safety Services Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Integrated
  • Standalone

Global Cardiac Safety Services Market Size by End Use & CAGR (2026-2033)

  • Market Overview
  • Pharma & Biopharma Companies
  • CROs
  • Others

Global Cardiac Safety Services Market Size & CAGR (2026-2033)

  • North America (Services, Type, End Use)
    • US
    • Canada
  • Europe (Services, Type, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Services, Type, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Services, Type, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Services, Type, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • IQVIA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PPD Inc,
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Welly sis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celerion
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nova Research Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratory Corporation of America Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Konin klije Philips N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICON Plc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGS S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clario
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Viva Link
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Certara
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Richmond Pharmacology
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotrial
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations